- Info
- Significant Ownership
Significant Ownership of Joseph S. Freedman
- Signature - Title
- /s/ Joseph S. Freedman - Joseph S. Freedman
- Location
- North York, Ontario, Canada
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Joseph S. Freedman.
Follow Filing Activity
Follow Joseph S. Freedman and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Joseph S. Freedman
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EPRX | Eupraxia Pharmaceuticals Inc. | Common Shares, no par value | 9% | $47,037,881 | +$2,495,500 | 5,843,215 | +5.6% | Joseph S. Freedman | 13 Mar 2026 |
Schedules 13D/G Reported by Joseph S. Freedman:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.